Skip to main content

Advertisement

Log in

Another Exciting Data—HCT Successfully Cured Patients with DADA2

A commentary on “Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients” by Hashem H et al.

  • Commentary
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data Availability

Not applicable.

References

  1. Meyts I, Aksentijevich I. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38:569–78.

    Article  CAS  Google Scholar 

  2. Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immun. 2020;145:1664-1672.e10.

    Article  CAS  Google Scholar 

  3. Jee H, Huang Z, Baxter S, Huang Y, Taylor ML, Henderson LA, et al. Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach. J Allergy Clin Immun. 2021. https://doi.org/10.1016/j.jaci.2021.04.034.

  4. Ombrello AK, Qin J, Hoffmann PM, Kumar P, Stone D, Jones A, et al. Treatment strategies for deficiency of adenosine deaminase 2. New Engl J Med. 2019;380:1582–4.

    Article  Google Scholar 

  5. Hashem H, Kumar AR, Müller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130:2682–8.

    Article  CAS  Google Scholar 

  6. Hashem H, Bucciol G, Ozen S, Unal S, Bozkayaa IO, Akarsu N, et al. Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients. J Clin Immunol. 2021. https://doi.org/10.1007/s10875-021-01098-0.

  7. Bucciol G, Delafontaine S, Segers H, Bossuyt X, Hershfield MS, Moens L, et al. Hematopoietic stem cell transplantation in ADA2 deficiency: early restoration of ADA2 enzyme activity and disease relapse upon drop of donor chimerism. J Clin Immunol. 2017;37:746–50.

    Article  CAS  Google Scholar 

  8. Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76:1648.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

M.Y. and T.M. wrote and reviewed the manuscript.

Corresponding author

Correspondence to Tomohiro Morio.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamashita, M., Morio, T. Another Exciting Data—HCT Successfully Cured Patients with DADA2. J Clin Immunol 41, 1443–1445 (2021). https://doi.org/10.1007/s10875-021-01121-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-021-01121-4

Navigation